Improving Outcomes in NTM-LD: Identifying Risk Factors and Applying New Guidelines to Practice

The goal of this activity is to provide clinicians with the clinical tools necessary to identify patients with NTM-LD in a timely manner and to offer the most state-of-the art guideline-recommended therapies for an adequate treatment response. Faculty share statistics on the increasing incidence of NTM-LD, patient risk factors for initial infection as well as progression of disease, and reasons for diagnostic delay. Current NTM-LD treatment guidelines are discussed, including the importance of airway clearance. Clinical insights are provided for treating refractory Mycobacterium avium complex lung disease, when is watchful waiting before treatment appropriate, how to manage important adverse effects of therapies, and the vital role for involving patients in their NTM-LD care.